NeoGenomics Inc.

NASDAQ: NEO · Real-Time Price · USD
6.21
0.01 (0.16%)
At close: Aug 15, 2025, 3:59 PM
6.29
1.21%
After-hours: Aug 15, 2025, 06:17 PM EDT

NeoGenomics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
689.19M 672.36M 660.57M 644.12M 628.25M 610.66M 591.64M 574.8M 551.62M 529.78M 509.73M 496.75M 489.31M 485.96M 484.33M 484.59M 488.7M 453.95M
Cost of Revenue
386.55M 377.94M 377.37M 370.59M 367.29M 358.86M 347.04M 340.95M 331.2M 325.3M 321.83M 320.43M 314.64M 302.25M 297.27M 285.34M 282.62M 272.85M
Gross Profit
302.64M 294.43M 283.2M 273.53M 260.96M 251.81M 244.6M 233.84M 220.42M 204.48M 187.9M 176.33M 174.67M 183.72M 187.06M 199.26M 206.08M 181.1M
Operating Income
-115.05M -87.82M -90.56M -90.73M -93.73M -103.23M -107.74M -115.55M -130.86M -140.67M -157.62M -172.81M -173.01M -155.68M -118.75M -71.65M -27.27M -23.81M
Interest Income
10.46M 17.31M 18.43M 18.94M 18.8M 18.51M 16.9M 12.92M 8.39M 4.08M 860K n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-104.73M -78.65M -80.67M -79.83M -83.44M -91.06M -97.1M -107.33M -125.51M -139.9M -159.34M -178.02M -161.57M -47.1M -15.08M 36.7M 62.09M -29.3M
Net Income
-104.04M -77.59M -78.73M -77.73M -78.55M -84.23M -87.97M -96.33M -114.67M -125.64M -144.25M -163.32M -146.82M -35.64M -8.35M 48.83M 71.73M -10.96M
Selling & General & Admin
360.08M 349.26M 344.39M 336.24M 327.95M 322.15M 313.94M 308.13M 310.13M 305.94M 310.68M 316.97M 315.42M 312.26M 283.94M 255.44M 223.33M 196.28M
Research & Development
34.86M 33.72M 31.16M 30.32M 27.92M 27.53M 27.31M 26.86M 28.88M 30.01M 30.33M 32.16M 32.26M 27.13M 21.87M 15.46M 10.02M 8.63M
Other Expenses
2.72M 4.26M 6.66M 6.16M 7.27M 5.73M 8.01M 6.81M 4.71M 4.3M -213K -212K -148K 428K 260K 260K 182K 11K
Operating Expenses
397.65M 387.24M 382.21M 372.71M 363.14M 355.42M 349.27M 344.78M 346.67M 343.61M 343.98M 349.13M 347.68M 339.39M 305.81M 270.9M 233.35M 204.9M
Interest Expense
5.82M 6.55M 6.62M 6.67M 6.72M 6.83M 6.91M 5.23M 3.68M 2.82M 2.37M 4.07M 5.23M 5.21M 5.08M 5.57M 6.73M 7.38M
Selling & Marketing Expenses
89.51M 87.11M 84.65M 80.39M 77.58M 74.8M 70.84M 69.91M 69.11M 67.28M 67.32M 66.1M 64.99M 65.14M 62.59M 59.78M 55.38M 48.35M
Cost & Expenses
784.2M 761.73M 752.67M 736.4M 723.52M 710.82M 696.3M 685.73M 677.87M 668.91M 665.82M 669.56M 662.32M 641.64M 603.08M 556.24M 515.96M 477.76M
Income Tax Expense
-688K -1.06M -1.95M -2.1M -4.89M -6.82M -9.13M -11.01M -10.84M -14.26M -15.09M -14.7M -14.75M -11.46M -6.73M -12.13M -9.65M -18.34M
Shares Outstanding (Basic)
25.59M 25.48M 25.33M 25.39M 25.28M 25.22M 25.19M 25.14M 25.07M 25.01M 24.94M 24.57M 24.81M 24.7M 24.52M 23.94M 23.66M 23.24M
Shares Outstanding (Diluted)
25.59M 25.48M 25.33M 25.39M 25.28M 25.22M 25.19M 25.14M 25.07M 25.01M 24.94M 24.89M 24.81M 24.73M 24.62M 24.51M 26.25M 23.24M
EPS (Basic)
-4.05 -3.05 -3.1 -3.05 -3.1 -3.3 -3.5 -3.85 -4.6 -5.05 -5.8 -6.6 -5.95 -1.35 -0.3 2.10 3.05 -0.47
EPS (Diluted)
-4.05 -3.05 -3.1 -3.05 -3.1 -3.3 -3.5 -3.85 -4.6 -5.05 -5.8 -6.6 -5.95 -1.6 -0.55 1.80 2.75 -0.5
EBITDA
-48.48M -93K -1.51M -439K -3.85M -11.2M -17.61M -30.68M -51.09M -65.25M -83.44M -100.76M -81.52M -72.43M -49.07M -4.04M 12.43M 16.09M
EBIT
-54.75M -72.1M -74.06M -73.16M -79.41M -86.92M -92.88M -105.66M -122.69M -137.94M -157.84M -173.95M -156.34M -138.6M -106.7M -54.44M -27.89M -21.93M
Depreciation & Amortization
53.9M 72.01M 72.55M 72.72M 72.87M 75.34M 74.9M 77.01M 76.34M 72.78M 71.83M 68.23M 69.83M 65.4M 59.52M 52.29M 42.21M 38.03M